Quantcast

All Posts Tagged Tag: ‘Prescription Drugs’

Hepatitis C Pill FDA Approved: Will They Lower The $100,000 Price Tag?

Hepatitis C drug Harvoni (which combines Solvadi with ledipasvir) was approved on Friday by the FDA. The prescription drug promises to cure Hepatitis C sufferers in as few as eight weeks. While the drug is meant to be an easy cure, it will likely remain out of the price range of most of the 3.2 million Americans who suffer from …

Read More

Medicare Drug Premiums Set to Rise Yet Again

In a sign of what may become the new normal over the next few decades, the U.S. Department of Health and Human Services this week announced that the price of Medicare premiums for prescription drugs will be rising again this year. This would mark the second year in a row that the average monthly Medicare prescription drug plan premium has …

Read More

New Painkiller Zohydro At Heart Of Major Controversy

There is no doubt that the proper dosage and usage of medication can go a long way towards helping individuals who suffer from conditions such as depression and anxiety. Even dangerously psychotic conditions that could lead persons to harm themselves or others can be greatly improved with the right medication. When a person is suffering from physical pain that is …

Read More

Acetaminophen Warning By FDA: Overdose Can Be Fatal

The FDA recently asked that healthcare providers be mindful of the dosage of Acetaminophen they choose to prescribe patients. According to the government regulatory agency, more than 325 mg of the drug could have negative consequences such as severe liver damage. In certain circumstances, an excessive dose of Acetaminophen might even be fatal. The FDA made the reasons for its …

Read More

Asthma Drug Rejected by U.K.’s NICE

The U.K.’s National Institute for Health and Clinical Excellence (NICE) this weekend issued a draft guidance stating that it does not recommend omalizumab, an asthma medication marketed as Xolair by Novartis Pharmaceuticals. NICE is a U.K. health authority that publishes guidelines for the National Health Service. Omalizumab currently has a U.K. marketing authorization as an add-on therapy for persistent allergic …

Read More

Cancer Treatment Kevetrin Begins Clinical Trials

Today the Cellceutix Corporation announced that its new anti-cancer drug candidate Kevetrin will soon be entering clinical trials at the Harvard Cancer Center’s Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center. Cellceutix is a biopharmaceutical company focused on small molecule drugs for the treatment of “unmet” medical conditions, such as drug-resistant cancers and autoimmune diseases. Kevetrin is Cellceutix’s name …

Read More

New MS Treatment Shown to Reduce Relapses

Two phase 3 clinical trials have shown that oral doses of a drug called BG-12 show “significant” and “clinically meaningful” reductions in multiple sclerosis (MS) relapses and brain lesions in people with a relapsing form of MS. The active ingredient in BG-12 is the compound dimethyl fumarate. The trials, which were published yesterday in the New England Journal of Medicine, …

Read More

Multiple Sclerosis Pill Approved by U.S. FDA

The U.S. FDA this week approved a once-a-day pill for the treatment of multiple sclerosis (MS). The pill, being branded as “Aubagio” by Sanofi S.A., is specifically for the treatment of adults with relapsing forms of MS. “In a clinical trial, the relapse rate for patients using Aubagio was about 30 percent lower than the rate for those taking a …

Read More

Leukemia Drug Approved by the FDA

Pfizer this week announced that Bosulif, a medication it developed for the treatment of a rare type of Leukemia, has been approved by the U.S. Food and Drug Administration. The medication is approved for the treatment of adults with chronic, accelerated, or blast phase Philadelphia chromosome-positive chronic myelogenous leukemia (CML) that has resisted prior therapy. The American Cancer Society estimates …

Read More

Herceptin Breast Cancer Drug Shown to Greatly Increase Heart Risks

A study by the Group Health Research Institute in Seattle has determined that trastuzumab, the drug behind the brand name Herceptin, raises the risks for heart problems in breast cancer patients much more than previously thought. Trastuzumab is widely prescribed alongside chemotherapy to increase survival chances for patients with breast cancer. Erin Bowles, an epidemiologist at the Group Health Research …

Read More

Is Google Guilty of Intentionally Marketing Canadian Prescription Drug Ads to Americans?

Google Inc. has until the 9th of April to give the Dekalb County Pension Fund investors company documents involving what authorities said was the illegal online marketing of prescription drugs to U.S. consumers by Canadian pharmacies. A Deleware judge entered the order Wednesday after a complaint was filed by the DeKalb County Pension Fund. Fund attorneys want to see corporate …

Read More